PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model-Reference-Cited by-同舟云学术

PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model

Published:2017-07 Issue:1 Volume:266 Page:91-98
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Zaidi Ali H.,Kosovec Juliann E.,Matsui Daisuke,Omstead Ashten N.,Raj Moses,Rao Rohit R.,Biederman Robert W. W.,Finley Gene G.,Landreneau Rodney J.,Kelly Ronan J.,Jobe Blair A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference49 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Oesophageal carcinoma;Pennathur;Lancet,2013

3. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century? A SEER Database Analysis;Dubecz;J Gastrointest Surg,2014

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

5. Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction;Hosoda;Gen Thorac Cardiovasc Surg,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and therapeutic potential of DNA-dependent protein kinase inhibitors;Bioorganic Chemistry;2024-09

2. Design of PI3K-mTOR Dual Inhibitors for Ovarian Cancer: Are We on the Right Track?;Current Medicinal Chemistry;2024-04-04

3. Roles of Rictor alterations in gastrointestinal tumors (Review);Oncology Reports;2024-01-04

4. Mycochemicals against Cancer Stem Cells;Toxins;2023-05-25

5. The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches;Current Molecular Medicine;2023-05-09